American Association for Cancer Research

AACR CANCER POLICY MONITOR

CPM

                                                                                                    JUNE 2010

Subscribe to the Cancer Policy Monitor


 

U.S. SENATOR'S DRIVE TO IMPROVE ACCESS TO CANCER CLINICAL TRIALS

Senator Sherrod Brown talks to the AACR about breaking down barriers to lifesaving trials

Senator Sherrod Brown (D-Ohio) has been a steadfast supporter of biomedical research in the U.S. Senate as well as the House of Representatives, where he served from 1993 to 2006. Read more

 


 

WHITE HOUSE ORDERS FEDERAL AGENCIES TO IDENTIFY BUDGET CUTS

Fiscal year 2012 budgets expected to be reduced by at least 5 percent

While Congress has barely begun its work on the fiscal year 2011 budget, the White House is already looking ahead to FY2012 with an eye on reducing non-security related domestic spending. Read more

 


 

NATIONAL CANCER RESEARCH MONTH OBSERVED ON CAPITOL HILL

Throughout the month of May, the AACR joined lawmakers to raise awareness about advances in cancer research

Members of the House and Senate paid tribute to the lifesaving contributions of cancer researchers across the nation and expressed support for a future of continued progress and innovation. Read more

 


 

JUNE 22 MARKS FIRST ANNIVERSARY OF HISTORIC TOBACCO LAW

AACR joins nationwide efforts to combat tobacco epidemic

Over the last year, the U.S. has taken momentous strides to reduce the toll of disease and death caused by tobacco. Read more

 


 

NIH PROPOSES NEW CONFLICT OF INTEREST RULE

Deadline for public input is July 20

Scientists funded by the National Institutes of Health (NIH) may soon be required to disclose more information about their financial ties to industry. Read more

 


 

FDA, KEY STAKEHOLDERS PREPARE FOR 2012 REAUTHORIZATION OF PDUFA

Prescription Drug User Fee Act intended to expedite drug approval process

Ensuring new regulatory science to support personalized medicine and 21st century medicine will be a primary focus as the U.S. Food and Drug Administration (FDA) prepares for the next reauthorization of the Prescription Drug User Fee Act (PDUFA). Read more

 


 


Top